A carregar...
Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
Tyrosinemia type 1 (TT1) is a rare metabolic disease caused by a defect in tyrosine catabolism. TT1 is clinically characterized by acute liver failure, development of hepatocellular carcinoma, renal and neurological problems, and consequently an extremely poor outcome. This review showed that the in...
Na minha lista:
| Publicado no: | Paediatr Drugs |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885500/ https://ncbi.nlm.nih.gov/pubmed/31667718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-019-00364-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|